282 related articles for article (PubMed ID: 33137362)
1. BIKE regulates dengue virus infection and is a cellular target for broad-spectrum antivirals.
Pu S; Schor S; Karim M; Saul S; Robinson M; Kumar S; Prugar LI; Dorosky DE; Brannan J; Dye JM; Einav S
Antiviral Res; 2020 Dec; 184():104966. PubMed ID: 33137362
[TBL] [Abstract][Full Text] [Related]
2. Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects.
Bekerman E; Neveu G; Shulla A; Brannan J; Pu SY; Wang S; Xiao F; Barouch-Bentov R; Bakken RR; Mateo R; Govero J; Nagamine CM; Diamond MS; De Jonghe S; Herdewijn P; Dye JM; Randall G; Einav S
J Clin Invest; 2017 Apr; 127(4):1338-1352. PubMed ID: 28240606
[TBL] [Abstract][Full Text] [Related]
3. The cargo adapter protein CLINT1 is phosphorylated by the Numb-associated kinase BIKE and mediates dengue virus infection.
Schor S; Pu S; Nicolaescu V; Azari S; Kõivomägi M; Karim M; Cassonnet P; Saul S; Neveu G; Yueh A; Demeret C; Skotheim JM; Jacob Y; Randall G; Einav S
J Biol Chem; 2022 Jun; 298(6):101956. PubMed ID: 35452674
[TBL] [Abstract][Full Text] [Related]
4. Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies.
Karim M; Saul S; Ghita L; Sahoo MK; Ye C; Bhalla N; Lo CW; Jin J; Park JG; Martinez-Gualda B; East MP; Johnson GL; Pinsky BA; Martinez-Sobrido L; Asquith CRM; Narayanan A; De Jonghe S; Einav S
Antiviral Res; 2022 Aug; 204():105367. PubMed ID: 35738348
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment.
Pu SY; Xiao F; Schor S; Bekerman E; Zanini F; Barouch-Bentov R; Nagamine CM; Einav S
Antiviral Res; 2018 Jul; 155():67-75. PubMed ID: 29753658
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
Virol J; 2011 Dec; 8():560. PubMed ID: 22201648
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses.
Zandi K; Bassit L; Amblard F; Cox BD; Hassandarvish P; Moghaddam E; Yueh A; Libanio Rodrigues GO; Passos I; Costa VV; AbuBakar S; Zhou L; Kohler J; Teixeira MM; Schinazi RF
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061163
[TBL] [Abstract][Full Text] [Related]
8. Determinants in Nonstructural Protein 4A of Dengue Virus Required for RNA Replication and Replication Organelle Biogenesis.
Cortese M; Mulder K; Chatel-Chaix L; Scaturro P; Cerikan B; Plaszczyca A; Haselmann U; Bartenschlager M; Neufeldt CJ; Bartenschlager R
J Virol; 2021 Oct; 95(21):e0131021. PubMed ID: 34379504
[TBL] [Abstract][Full Text] [Related]
9. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
Kuo YT; Liu CH; Li JW; Lin CJ; Jassey A; Wu HN; Perng GC; Yen MH; Lin LT
Sci Rep; 2020 Oct; 10(1):16378. PubMed ID: 33009425
[TBL] [Abstract][Full Text] [Related]
10. AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.
Neveu G; Ziv-Av A; Barouch-Bentov R; Berkerman E; Mulholland J; Einav S
J Virol; 2015 Apr; 89(8):4387-404. PubMed ID: 25653444
[TBL] [Abstract][Full Text] [Related]
11. Betulinic acid exhibits antiviral effects against dengue virus infection.
Loe MWC; Hao E; Chen M; Li C; Lee RCH; Zhu IXY; Teo ZY; Chin WX; Hou X; Deng J; Chu JJH
Antiviral Res; 2020 Dec; 184():104954. PubMed ID: 33080251
[TBL] [Abstract][Full Text] [Related]
12. Suppression of µ1 subunit of the adaptor protein complex 2 reduces dengue virus release.
Tongmuang N; Yasamut U; Noisakran S; Sreekanth GP; Yenchitsomanus PT; Limjindaporn T
Virus Genes; 2020 Feb; 56(1):27-36. PubMed ID: 31720911
[TBL] [Abstract][Full Text] [Related]
13. Drug repurposing of quinine as antiviral against dengue virus infection.
Malakar S; Sreelatha L; Dechtawewat T; Noisakran S; Yenchitsomanus PT; Chu JJH; Limjindaporn T
Virus Res; 2018 Aug; 255():171-178. PubMed ID: 30055216
[TBL] [Abstract][Full Text] [Related]
14. An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target.
Howe MK; Speer BL; Hughes PF; Loiselle DR; Vasudevan S; Haystead TA
Antiviral Res; 2016 Jun; 130():81-92. PubMed ID: 27058774
[TBL] [Abstract][Full Text] [Related]
15. Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus.
Franco EJ; Pires de Mello CP; Brown AN
Viruses; 2021 Apr; 13(5):. PubMed ID: 33925551
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses.
Quintana VM; Selisko B; Brunetti JE; Eydoux C; Guillemot JC; Canard B; Damonte EB; Julander JG; Castilla V
Antiviral Res; 2020 Apr; 176():104749. PubMed ID: 32081740
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis.
Wang QY; Bushell S; Qing M; Xu HY; Bonavia A; Nunes S; Zhou J; Poh MK; Florez de Sessions P; Niyomrattanakit P; Dong H; Hoffmaster K; Goh A; Nilar S; Schul W; Jones S; Kramer L; Compton T; Shi PY
J Virol; 2011 Jul; 85(13):6548-56. PubMed ID: 21507975
[TBL] [Abstract][Full Text] [Related]
18. Dengue Virus Evolution under a Host-Targeted Antiviral.
Plummer E; Buck MD; Sanchez M; Greenbaum JA; Turner J; Grewal R; Klose B; Sampath A; Warfield KL; Peters B; Ramstedt U; Shresta S
J Virol; 2015 May; 89(10):5592-601. PubMed ID: 25762732
[TBL] [Abstract][Full Text] [Related]
19. A Genome-Wide CRISPR-Cas9 Screen Identifies the Dolichol-Phosphate Mannose Synthase Complex as a Host Dependency Factor for Dengue Virus Infection.
Labeau A; Simon-Loriere E; Hafirassou ML; Bonnet-Madin L; Tessier S; Zamborlini A; Dupré T; Seta N; Schwartz O; Chaix ML; Delaugerre C; Amara A; Meertens L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915280
[TBL] [Abstract][Full Text] [Related]
20. Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity.
Pu SY; Wouters R; Schor S; Rozenski J; Barouch-Bentov R; Prugar LI; O'Brien CM; Brannan JM; Dye JM; Herdewijn P; De Jonghe S; Einav S
J Med Chem; 2018 Jul; 61(14):6178-6192. PubMed ID: 29953812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
